Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies

Immunology

Volumn 132, Issue 1, 2011, Pages 123-133

  Bermejo, Daniela A ^a   Amezcua Vesely, Maria Carolina ^a,a   Khan, Mahmood ^b   Acosta Rodríguez, Eva V ^a   Montes, Carolina L ^a   Toellner, Kai Michael ^b   Mohr, Elodie ^b   Taylor, Dale ^b   Cunningham, Adam F ^b   Gruppi, Adriana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antibody responses; B cells; Chagas' disease; Germinal centre; Parasite

Indexed keywords

CD45 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARASITE ANTIBODY; SYNDECAN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW; CHAGAS DISEASE; CONTROLLED STUDY; GERMINAL CENTER; LYMPHOCYTE COUNT; MICROENVIRONMENT; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 78650017817     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03347.x     Document Type: Article

References (40)

1. Hotez PJ, Bottazzi ME, Franco-Paredes C et al. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2008; 2:e300.
2. Minoprio P, Burlen O, Pereira P et al. Most B cells in acute Trypanosoma cruzi infection lack parasite specificity. Scand J Immunol 1998; 28:553-61.
3. Spinella S, Liegeard P, Hontebeyrie-Joskowicz M. Trypanosoma cruzi: predominance of IgG2a in nonspecific humoral response during experimental Chagas' disease. Exp Parasitol 1992; 74:46-56.
4. Kierszenbaum F, Howard JG. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice. J Immunol 1976; 116:1208-11.
5. Sepulveda P, Hontebeyrie M, Liegeard P et al. DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Infect Immun 2000; 68:4986-91.
6. Acosta-Rodriguez EV, Montes CL, Motran CC et al. Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. J Immunol 2004; 172:493-502.
7. Minoprio PM, Eisen H, Forni L et al. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scand J Immunol 1986; 24:661-8.
8. -T cells in the polyclonal lymphocyte responses to murine T. cruzi infection. Int Immunol 1989; 1:176-84.
9. Maclennan IC, Toellner KM, Cunningham AF et al. Extrafollicular antibody responses. Immunol Rev 2003; 194:8-18.
10. Jacob J, Kassir R, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med 1991; 173:1165-75.
11. Liu YJ, Zhang J, Lane PJ et al. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991; 21:2951-62.
12. Toellner KM, Luther SA, Sze DM et al. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 1998; 20:187.
13. Phan TG, Gardam S, Basten A et al. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J Immunol 2005; 15:174.
14. Cunningham AF, Gaspal F, Serre K et al. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol 2007; 178:6200-7.
15. Gil-Cruz C, Bobat S, Marshall JL et al. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci USA 2009; 106:9803-8.
16. Smelt SC, Engwerda CR, McCrossen M et al. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol 1997; 158:3813-21.
17. +B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide. J Immunol 2002; 168:3965-73.
18. Zuniga E, Acosta-Rodriguez E, Merino MC et al. Depletion of immature B cells during Trypanosoma cruzi infection: involvement of myeloid cells and the cyclooxygenase pathway. Eur J Immunol 2005; 35:1849-58.
19. Luther SA, Gulbranson-Judge A, Cha-Orbea H et al. Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med 1997; 185:551-62.
20. +cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur J Immunol 2006; 36:1474-85.
21. Camargo EP. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop Sao Paulo 1964; 12:93-100.
22. Zuniga E, Montes C, Barbieri G et al. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients. Clin Immunol 1999; 93:81-9.
23. Laderach D, Cerban F, Motran C et al. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). Int J Parasitol 1996; 26:1249-54.
24. Achtman AH, Khan M, Maclennan IC et al. Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol 2003; 171:317-24.
25. Carvalho LJ, Ferreira-da-Cruz MF, Daniel-Ribeiro CT et al. Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar J 2007; 6:59. 1475-2875-6-59.
26. Hofer T, Muehlinghaus G, Moser K et al. Adaptation of humoral memory. Immunol Rev 2006; 211:295-302.
27. Radbruch A, Muehlinghaus G, Luger EO et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006; 6:741-50.
28. Hontebeyrie-Joskowicz M, Minoprio P. Chagas' disease: Trypanosoma cruzi vs. the host immune system. Res Immunol 1991; 142:125-6.
29. Reina-San-Martin B, Degrave W, Rougeot C et al. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med 2000; 6:890-7.
30. Reina-San-Martin B, Cosson A, Minoprio P. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitol Today 2000; 16:62-7. Review.
31. Fink K, Manjarrez-Orduño N, Schildknecht A et al. B cell activation state-governed formation of germinal centers following viral infection. J Immunol 2007; 179:5877-85.
32. Mohr E, Serre K, Manz RA et al. Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J Immunol 2009; 182:2113-23.
33. Abreu-Silva AL, Calabrese KS, Cupolilo SM et al. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected. Vet Parasitol 2004; 121:179-87.
34. Pyrrho AS, Moraes JL, Pecanha LM et al. Trypanosoma cruzi: IgG1 and IgG2b are the main immunoglobulins produced by vaccinated mice. Parasitol Res 1998; 84:333-7.
35. McHeyzer-Williams LJ, Malherbe LP, McHeyzer-Williams MG. Helper T cell-regulated B cell immunity. Curr Top Microbiol Immunol 2006; 311:59-83. Review.
36. Minoprio P, Eisen H, Joskowicz M et al. Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies. J Immunol 1987; 139:545-50.
37. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol 2003; 3:822-9.
38. Manz RA, Hauser AE, Hiepe F et al. Maintenance of serum antibody levels. Annu Rev Immunol 2005; 23:367-86. 10.
39. Moser K, Tokoyoda K, Radbruch A et al. Stromal niches, plasma cell differentiation and survival. Curr Opin Immunol 2006; 18:265-70.
40. Merino MC, Montes CL, Acosta-Rodriguez EV et al. Peritoneum from Trypanosoma cruzi infected mice is a homing site of Syndecan-1neg plasma cells which mainly provide non-parasite specific antibodies. Int Immunol 2010; 22:399-410.